Your browser doesn't support javascript.
Estimation of Secondary Household Attack Rates for Emergent Spike L452R Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants Detected by Genomic Surveillance at a Community-Based Testing Site in San Francisco.
Peng, James; Liu, Jamin; Mann, Sabrina A; Mitchell, Anthea M; Laurie, Matthew T; Sunshine, Sara; Pilarowski, Genay; Ayscue, Patrick; Kistler, Amy; Vanaerschot, Manu; Li, Lucy M; McGeever, Aaron; Chow, Eric D; Marquez, Carina; Nakamura, Robert; Rubio, Luis; Chamie, Gabriel; Jones, Diane; Jacobo, Jon; Rojas, Susana; Rojas, Susy; Tulier-Laiwa, Valerie; Black, Douglas; Martinez, Jackie; Naso, Jamie; Schwab, Joshua; Petersen, Maya; Havlir, Diane; DeRisi, Joseph.
  • Peng J; Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, San Francisco, California, USA.
  • Liu J; Department of Biochemistry and Biophysics, University of California, San Francisco, California, USA.
  • Mann SA; University of California, Berkeley-University of California, San Francisco Graduate Program in Bioengineering, Berkeley, California, USA.
  • Mitchell AM; Department of Biochemistry and Biophysics, University of California, San Francisco, California, USA.
  • Laurie MT; Chan Zuckerberg Biohub, San Francisco, California, USA.
  • Sunshine S; Department of Biochemistry and Biophysics, University of California, San Francisco, California, USA.
  • Pilarowski G; Chan Zuckerberg Biohub, San Francisco, California, USA.
  • Ayscue P; Department of Biochemistry and Biophysics, University of California, San Francisco, California, USA.
  • Kistler A; Department of Biochemistry and Biophysics, University of California, San Francisco, California, USA.
  • Vanaerschot M; Department of Pathology, Stanford University, Stanford, California, USA.
  • Li LM; Chan Zuckerberg Biohub, San Francisco, California, USA.
  • McGeever A; Chan Zuckerberg Biohub, San Francisco, California, USA.
  • Chow ED; Chan Zuckerberg Biohub, San Francisco, California, USA.
  • Marquez C; Chan Zuckerberg Biohub, San Francisco, California, USA.
  • Nakamura R; Chan Zuckerberg Biohub, San Francisco, California, USA.
  • Rubio L; Department of Biochemistry and Biophysics, University of California, San Francisco, California, USA.
  • Chamie G; Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, San Francisco, California, USA.
  • Jones D; California Department of Public Health, Richmond, California, USA.
  • Jacobo J; Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, San Francisco, California, USA.
  • Rojas S; Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, San Francisco, California, USA.
  • Rojas S; Unidos en Salud, San Francisco, California, USA.
  • Tulier-Laiwa V; Unidos en Salud, San Francisco, California, USA.
  • Black D; Unidos en Salud, San Francisco, California, USA.
  • Martinez J; Unidos en Salud, San Francisco, California, USA.
  • Naso J; Unidos en Salud, San Francisco, California, USA.
  • Schwab J; Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, San Francisco, California, USA.
  • Petersen M; Unidos en Salud, San Francisco, California, USA.
  • Havlir D; Unidos en Salud, San Francisco, California, USA.
  • DeRisi J; Division of Biostatistics, University of California, Berkeley, Berkeley, California, USA.
Clin Infect Dis ; 74(1): 32-39, 2022 01 07.
Article in English | MEDLINE | ID: covidwho-1636422
ABSTRACT

BACKGROUND:

Sequencing of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral genome from patient samples is an important epidemiological tool for monitoring and responding to the pandemic, including the emergence of new mutations in specific communities.

METHODS:

SARS-CoV-2 genomic sequences were generated from positive samples collected, along with epidemiological metadata, at a walk-up, rapid testing site in the Mission District of San Francisco, California during 22 November to 1 December, 2020, and 10-29 January 2021. Secondary household attack rates and mean sample viral load were estimated and compared across observed variants.

RESULTS:

A total of 12 124 tests were performed yielding 1099 positives. From these, 928 high-quality genomes were generated. Certain viral lineages bearing spike mutations, defined in part by L452R, S13I, and W152C, comprised 54.4% of the total sequences from January, compared to 15.7% in November. Household contacts exposed to the "California" or "West Coast" variants (B.1.427 and B.1.429) were at higher risk of infection compared to household contacts exposed to lineages lacking these variants (0.36 vs 0.29, risk ratio [RR] = 1.28; 95% confidence interval [CI] 1.00-1.64). The reproductive number was estimated to be modestly higher than other lineages spreading in California during the second half of 2020. Viral loads were similar among persons infected with West Coast versus non-West Coast strains, as was the proportion of individuals with symptoms (60.9% vs 64.3%).

CONCLUSIONS:

The increase in prevalence, relative household attack rates, and reproductive number are consistent with a modest transmissibility increase of the West Coast variants.

Summary:

We observed a growing prevalence and modestly elevated attack rate for "West Coast" severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants in a community testing setting in San Francisco during January 2021, suggesting its modestly higher transmissibility.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Observational study / Prognostic study Topics: Variants Limits: Humans Country/Region as subject: North America Language: English Journal: Clin Infect Dis Journal subject: Communicable Diseases Year: 2022 Document Type: Article Affiliation country: Cid

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Observational study / Prognostic study Topics: Variants Limits: Humans Country/Region as subject: North America Language: English Journal: Clin Infect Dis Journal subject: Communicable Diseases Year: 2022 Document Type: Article Affiliation country: Cid